The EU's drugs regulator has approved the use of the Oxford-AstraZeneca Covid vaccine for all adults.
The European Medicines Agency (EMA) said the AstraZeneca vaccine was about 60% effective in the trials on which it based its decision.
The move comes amid a dispute over whether AstraZeneca is breaking its vaccine delivery commitments to the EU.
The European Commission has published its contract with the Anglo-Swedish drug-maker, hoping to show a breach.
The bloc agreed to buy up to 400 million doses of the AstraZeneca vaccine last year.
In a press conference later on Friday, Astra-Zeneca chief executive Pascal Soriot said that while "of course there will be glitches" in manufacturing, the important thing was that the world had developed several vaccines within a year.
Mr Soriot said AstraZeneca had millions of doses ready to ship to the EU, and was working 24/7 to increase capacity.
The European Commission has now given final approval for the vaccine.
https://www.bbc.co.uk/news/world-europe-55862233
The European Medicines Agency (EMA) said the AstraZeneca vaccine was about 60% effective in the trials on which it based its decision.
The move comes amid a dispute over whether AstraZeneca is breaking its vaccine delivery commitments to the EU.
The European Commission has published its contract with the Anglo-Swedish drug-maker, hoping to show a breach.
The bloc agreed to buy up to 400 million doses of the AstraZeneca vaccine last year.
In a press conference later on Friday, Astra-Zeneca chief executive Pascal Soriot said that while "of course there will be glitches" in manufacturing, the important thing was that the world had developed several vaccines within a year.
Mr Soriot said AstraZeneca had millions of doses ready to ship to the EU, and was working 24/7 to increase capacity.
The European Commission has now given final approval for the vaccine.
https://www.bbc.co.uk/news/world-europe-55862233